-
Genetic change reveals precision medicine possibilities for a high-risk leukemia
A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
-
Mobile health app to help sickle cell patients
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
-
Researchers uncover genetic hallmarks of ALL subtype
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
-
Researchers reveal genomic landscape of CBF-AML
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
-
Chemo drug impairs multitasking for some survivors
Methotrexate exposure tied to reduced mental flexibility, planning and other executive function skills in long-term survivors of pediatric leukemia.
-
Patient safety benefits when hospitals provide feedback
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
From Promise, Winter 2017